All tobacco products, even when produced to the highest quality standards, pose real and serious risks to health.
Risk awareness among consumers is constantly reinforced by health warnings on primary packaging mandated by the majority of governments. Our approach to tobacco harm reduction is to pursue the research, development and test marketing of innovative tobacco products that will have consumer acceptability, and will be recognised by the scientific and public health communities and regulators as posing reduced risks to health. For more information, please see the Harm reduction section of this Report.
In the context of possible product deterioration or contamination, our companies follow a common approach to assuring product integrity. This seeks to minimise the risk of product integrity issues arising, through risk assessment and controls across our product design and supply chain, and to ensure the appropriate response capability should a product integrity issue arise through incidents within or beyond our control.
Save as reported elsewhere in these GRIs, no instances were reported by our companies in 2009.
Where health warnings on packaging are not required by local laws or regulations, our Health Warnings on Cigarette Packaging policy requires Group companies to comply with any voluntary codes in force or, in the absence of these, to follow Group guidelines in placing an appropriate health warning on packaging.
See also PR6 and PR7 for details of our voluntary International Tobacco Products Marketing Standards.
In 2009, the following matters were reported by our companies:
£ equivalent based on the same average currency conversion rates as used for the Group Income Statement in the Annual Report 2009
.
Our companies have a common market and information system including:
Our companies are also encouraged to adopt consumer feedback mechanisms such as call centres, websites and mail response suited to the local environment. The biannual Customer Satisfaction Measurement among key distribution and retail partners is carried out in our top markets, providing feedback on service quality and other aspects of our business relationship, and comparing British American Tobacco with its key competitors and top consumer goods companies servicing the same retailers. The results of the most recent survey are available on www.bat.com/consumers
.
In 2001, we collaborated with other international tobacco companies to establish a set of voluntary International Tobacco Products Marketing Standards (IMS) and in 2007 we updated them, in response to stakeholder dialogue and without the collaboration of the rest of the industry. Our updated Standards include, for example, further procedures for adult verification and responsible use of new media such as the internet and other electronic messaging.
The Standards require that marketing activities should not be aimed at, or particularly appeal to, youth, and not feature celebrities nor link tobacco with sporting, professional, social or sexual success. They also state that advertising should not appear in printed publications unless at least 75 per cent of readers are verified as adults and that all marketing materials must carry a health warning as well as the health warnings on product packs.
Group companies must report annually on their level of adherence with the Standards. Adherence by our companies is monitored by our regional audit and CSR committees and updates reported to our Board CSR Committee. For information on adherence to our International Marketing Standards, including progress on actions from our 2008 review and adherence in 2009, please see the Marketplace section of this Report and PR7.
To download the Standards in full, go to www.bat.com/marketingstandards
.
In 2008, we reviewed how our companies were applying our International Market Standards (IMS) which had been updated with further requirements to be met in 2008. The assessment reported an adherence rate of 97 per cent, but also some inconsistencies in the interpretation of the Standards. In 2009 we addressed these issues, with progress monitored by our regional audit and CSR committees, and updates reported to our Board CSR Committee. Examples of actions taken include:
At the end of 2009 all actions to address issues identified in the 2008 review had been completed in all but two markets. Both are expected to be complete by mid-2010.
In 2009, 12 companies reported a total of 15 instances of non-adherence to our IMS. Action plans were in place by year end, with the aim of achieving full adherence in 2010.
In addition, the marketing activities of the business that we acquired in Indonesia in mid-2009, and where we took control in January 2010, do not adhere to our IMS. Indonesia is not currently a signatory to the World Health Organisation’s Framework Convention on Tobacco Control and the market is very lightly regulated. Our plans to introduce IMS have been overtaken by proposed regulations from the Ministry of Health. However, we are committed to bringing our operations in Indonesia in line with our IMS as soon as is practical and will, of course, comply with any new regulations.
For 2009, our companies reported the following matters:
£ equivalent based on the same average currency conversion rates as used for the Group Income Statement in the Annual Report 2009
.
In 2009, no material instances were reported by our companies.
Save as reported elsewhere in these GRIs, no instances were reported by our companies in 2009.